Physician profile
Nicholas Mantini
NPI 1588808646
$38,631.27
in general payments reported to CMS, 2019-2025
11 companies · $3,472 in 2025
The $3,472 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,418 · 2021: $747 · 2022: $3,037 · 2023: $7,752 · 2024: $4,871 · 2025: $3,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $8,902 · Food and Beverage: $7,192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $8,901.91 |
| Food and Beverage | $7,192.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $24,812.31 | 2019-2025 | Farapulse, Watchman Access System, Accolade Sr |
| Abbott Laboratories | $8,104.69 | 2019-2025 | Ensite Precision, Ensite, Viewmate |
| Medtronic, INC. | $4,480.16 | 2021-2025 | Evera Mri Xt Dr Surescan, Aurora Ev-Icd Mri Surescan, Azure Xt Dr Mri Surescan |
| Cook Medical LLC | $435.43 | 2022-2024 | Evolution |
| Medtronic Vascular, INC. | $307.46 | 2019 | |
| Biosense Webster, INC. | $290.85 | 2022-2024 | Carto 3 |
| Siemens Medical Solutions USA, INC. | $111.50 | 2023 | Artis Icono Floor |
| Philips North America LLC | $25.75 | 2024 | (9148) Ice 3d |
| Shockwave Medical, INC | $23.11 | 2025 | |
| Abiomed | $21.86 | 2023 | Impella |
| Pfizer INC. | $18.15 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Mantini listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.